A Study of CYFRA21-1,β2-MG and SCC-Ag Expression Levels and Their  Relationships with Efficacy of Chemotherapy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

doi:10.11748/bjmy.issn.1006-1703.2018.11.034

PDF(3677 KB)

Labeled Immunoassays and Clinical Medicine ›› 2018, Vol. 25 ›› Issue (11) : 1716-1720. DOI: 10.11748/bjmy.issn.1006-1703.2018.11.034

A Study of CYFRA21-1,β2-MG and SCC-Ag Expression Levels and Their Relationships with Efficacy of Chemotherapy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 25(11): 1716-1720 https://doi.org/10.11748/bjmy.issn.1006-1703.2018.11.034

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3677 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2018-07-06	2018-09-07	2018-11-20
Issue Date
2019-02-06

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS